TipRanks
Go Ultimate55% OFF

Compare Cordlife Group (CLIFF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CLIFFCordlife Group$0.13$18.15M-2.1842.22%―Unlock the CLIFF analyst price target with TipRanks PremiumCLIFFUnlock the CLIFF top-analyst price target with TipRanks Premium
SG:BSLRaffles Medical GroupSGD 0.82SGD 1.55B22.40-17.68%Moderate BuyUnlock the SG:BSL analyst price target with TipRanks PremiumCLIFF vs SG:BSLUnlock the SG:BSL top-analyst price target with TipRanks Premium
SG:A50Thomson Medical Group Ltd.SGD 0.05SGD 1.27B-41.13-18.64%Moderate BuyUnlock the SG:A50 analyst price target with TipRanks PremiumCLIFF vs SG:A50Unlock the SG:A50 top-analyst price target with TipRanks Premium
SG:40TISEC Healthcare LtdSGD 0.31SGD 178.35M14.83-8.82%―Unlock the SG:40T analyst price target with TipRanks PremiumCLIFF vs SG:40TUnlock the SG:40T top-analyst price target with TipRanks Premium
SG:5WAOUE Lippo Healthcare LimitedSGD 0.05SGD 217.71M-7.3175.00%―Unlock the SG:5WA analyst price target with TipRanks PremiumCLIFF vs SG:5WAUnlock the SG:5WA top-analyst price target with TipRanks Premium
SG:TBDDBangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 ShSGD 1.50SGD 11.83B―-0.66%―Unlock the SG:TBDD analyst price target with TipRanks PremiumCLIFF vs SG:TBDDUnlock the SG:TBDD top-analyst price target with TipRanks Premium

Performance Comparison

-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CLIFFCordlife Group0.130.0442.22%
SG:BSLRaffles Medical Group0.81-0.15-15.10%
SG:A50Thomson Medical Group Ltd.0.05-0.01-20.00%
SG:40TISEC Healthcare Ltd0.31-0.02-6.91%
SG:5WAOUE Lippo Healthcare Limited0.050.0268.97%
SG:TBDDBangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh1.500.042.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts